Latest Bevacizumab Stories
a team of ophthalmologists at the University of Iowa has shown that Eylea an ease leaking and vision problems for wet AMD patients.
Funded by volleyball tournaments, a new study released this week shows success in pinpointing individualized treatment for women with metastatic breast cancer, according to George Mason University researchers.
Results of a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group (RTOG) determined that adding bevacizumab to initial treatment for glioblastoma (GBM) did not improve patient overall survival or progression-free survival.
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting.
A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin®).
- To give a box on the ear to.